Compounds for central reactivation of organophosphorus-based compound-inhibited acetylcholinesterase and/or inactivation of organophosphorus-based acetylcholinesterase inhibitors and related compositions methods and systems for making and using them
Described herein are oxime compounds capable of inactivating OP-based AChE inhibitors, crossing the blood brain barrier (BBB), and/or reactivation of OP-inhibited acetylcholinesterase (AChE) and related methods, systems and compositions for inactivation of one or more OP-based AChE inhibitors, therapeutic and/or prophylactic treatment of an individual, and/or decomposition of OP-based AChE inhibitors for decontamination.
1. A compound of Formula (IV)
wherein
R1=H;
R11 is H,
R12 is a linear or branched, alkyl, alkenyl, alkynyl group having equal to or less than 8 carbon atoms, wherein the alkyl, alkenyl, alkynyl groups can optionally independently be interrupted by one to six heteroatoms and/or include one to three substituents,
R13, is H, a linear or branched, alkyl, alkenyl, alkynyl group, having equal to or less than 8 carbon atoms, wherein the alkyl, alkenyl, alkynyl, groups can optionally independently be interrupted by one to six heteroatoms and/or include one to three substituents;
R161, R162, R163, and R164 are independently H, a linear or branched, alkyl, alkenyl, alkynyl, groups having equal to or less than 4 carbon atoms, wherein the alkyl, alkenyl, alkynyl, groups can optionally independently be interrupted by one to two heteroatoms and/or include one to three substituents,
wherein the heteroatoms are selected from the group consisting of N, O, S, P and Si,
wherein the substituents are selected from the group consisting of OH, NO2, CO2R′, CONHR′, COR′, F, Cl, CF3, CCl3, CN, OR′, NR′R″, vinyl group, wherein R′ and R″ are each independently a C1-C3 alkyl group or C1-C3 alkenyl group or a C1-C3 alkynyl group;
Q1, and Q4, are CH;
Q2, Q3 are independently selected from C, N, O, or S;
Q6 and Q7 are C;
N, Q1, Q4, Q6, and Q7 together form a saturated ring;
Q2, Q3, Q6 and Q7 together form an aromatic ring or a heteroaromatic ring;
1a, 2a, 3a and 4a are independently 0, 1, 2, 3, or 4;
1a and 4a together is equal to or less than 5;
2a and 3a together is equal to or less than 4;
2a and 3a together is at least 1.
2. A compound having Formula (VII)
wherein
R1=H;
R11 is H; R12 is a C1-C4 a linear or branched, alkyl, alkenyl, alkynyl group;
R13 is H or a C1-C4 a linear or branched, alkyl, alkenyl, alkynyl group;
R161, and R164 are independently H, a linear or branched, alkyl, alkenyl, alkynyl, groups having equal to or less than 4 carbon atoms, wherein the alkyl, alkenyl, alkynyl, groups can optionally independently be interrupted by one to two heteroatoms and/or include one to three substituents, wherein the heteroatoms are selected from the group consisting of N, O, S, P and Si;
wherein the substituents are selected from the group consisting of OH, NO2, CO2R′, CONHR′, COR′, F, Cl, CF3, CCl3, CN, OR′, NR′R″, vinyl group, wherein R′ and R″ are each independently a C1-C3 alkyl group or C1-C3 alkenyl group or a C1-C3 alkynyl group;
Q1, and Q4 are CH;
Q1, Q4 form part of a saturated ring;
1a, and 4a are independently 0, 1, 2, 3, or 4;
1a, and 4a together is equal or less than 5;
each of the 0-4 R221 is independently selected from the group consisting of NO 2 , CO 2 R′, CONHR′, COR′, F, Cl, CF 3 , CCl 3 , CN, OR′, NR′R″, R′, vinyl group, wherein R′ and R″ are each independently a C1-C3 alkyl group or C1-C3 alkenyl group or a C1-C3 alkynyl group; and R9 is H.
3. The compound of claim 1 , wherein 2a is 1 and Q2 is N, O or S.
4. The compound of claim 1 , wherein 2a is 1 and Q2 is N.
5. The compound of claim 1 , wherein 3a is 1 and Q3 is N.
6. The compound of claim 1 , wherein R12 is methyl group.
7. The compound of claim 1 , wherein R13 is H.
8. The compound of claim 1 , wherein R12 is methyl group and R13 is H.
9. A compound having a Formula (XXIII)
wherein
R161, and R164 are independently H, a linear or branched, alkyl, alkenyl, alkynyl, groups having equal to or less than 4 carbon atoms, wherein the alkyl, alkenyl, alkynyl, groups can optionally independently be interrupted by one to two heteroatoms and/or include one to three substituents, wherein the heteroatoms are selected from the group consisting of N, O, S, P and Si;
wherein the substituents are selected from the group consisting of OH, NO2, CO2R′, CONHR′, COR′, F, Cl, CF3, CCl3, CN, OR′, NR′R″, vinyl group, wherein R′ and R″ are each independently a C1-C3 alkyl group or C1-C3 alkenyl group or a C1-C3 alkynyl grow;
Q1, and Q4 are CH;
Q1, and Q4 form part of a saturated ring;
1a, and 4a are independently 0, 1, 2, 3, or 4;
1a, and 4a together are equal or less than 5;
each of the 0-4 R221 is independently selected from the group consisting of NO 2 , CO 2 R′, CONHR′, COR′, F, Cl, CF 3 , CCl 3 , CN, OR′, NR′R″, R′, vinyl group, wherein R′ and R″ are each independently a C1-C3 alkyl group or C1-C3 alkenyl group or a C1-C3 alkynyl group; and R9 is H.
10. The compound of claim 9 , wherein (R 221 ) 0-4 is (R 221 ) 0 .
11. The compound of claim 9 , wherein R 161 is H and 1a is 3.
12. The compound of claim 9 , wherein R 164 is H and 4a is 1.
13. The compound of claim 9 , wherein (R 221 ) 0-4 is (R 221 ) 0 ; R 164 is H; and 4a is 1.
14. The compound of claim 9 , wherein (R 221 ) 0-4 is (R 221 ) 0 ; R 161 is H; and 1a is 3.
15. A compound having a Formula (LLNL-02)